|Articles|January 15, 2002
- BioPharm International-01-01-2002
- Volume 15
- Issue 1
Liposomes (a Review): Part Two, Drug Delivery Systems
by Suggy S. Chrai, R. Murari, and Imran Ahmad Good manufacturing processes require that lipid vesicles be reproducibly uniform in size, carry the drug in sufficient concentration, and remain stable for an acceptable shelf-life under varying temperatures. Following these guidelines improves the analytical processes that support biopharmaceutical drug development.
Advertisement
Articles in this issue
about 24 years ago
Inside Washington: Biotechnology in the Limelight, the Year Aheadabout 24 years ago
Your Vested Interests: The War of the Westabout 24 years ago
Statistics for Laboratory Method Comparison Studiesabout 24 years ago
From the Editor: Farewell to 2001 . . . Our Biotech Odyssey Continuesabout 24 years ago
Information Age AuditsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
2
Next-Generation Modalities Drive New Antibody Discovery
3
Green Chemistry’s Role in Advancing US Chemical Innovation
4
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
5
